Table 2.

Prevalence of cardiovascular risk factors in the study participants stratified by gender and macro-area; Italy, 2007

	Study population			North-west			North-east			Centre			South			Islands
	Men	Women	P†	Men	Women	P†	Men	Women	P†	Men	Women	P†	Men	Women	P†	Men	Women	P†	P‡
Obesity (%)	26·1	18·9	0·003	20·5	15·2	0·041	19·9	12·9	0·001	24·2	18·1	0·010	31·5	23·5	0·020	24·6	16·8	0·004	0·001
Overweight (%)	56·7	31·6	0·001	55·3	29·2	0·001	56·0	32·2	0·001	57·5	32·5	0·016	52·6	32·3	0·017	57·5	30·8	0·010	0·001
High waist circumference (%)	57·0	56·4	0·001	53·8	53·0	0·001	52·9	51·8	0·001	53·6	58·1	0·028	60·3	60·6	0·022	61·5	53·9	0·044	0·001
Hypertension (%)	70·0	48·3	0·001	73·4	52·1	0·001	73·4	51·0	0·001	72·5	47·0	0·022	69·3	48·2	0·009	61·0	40·6	0·010	0·001
Hypercholesterolaemia (%)	26·8	32·7	0·001	29·0	35·2	0·001	29·7	34·9	0·001	26·5	33·2	0·028	25·9	29·3	0·001	24·6	32·9	0·001	0·001
Hypertriacylglycerolaemia (%)	47·8	43·1	0·002	48·7	48·1	0·022	52·0	45·8	0·002	49·6	45·8	0·010	46·7	38·5	0·512	43·1	36·5	0·248	0·001
Lipid-lowering therapy (%)	9·5	9·0	0·007	9·5	10·5	0·001	6·5	7·8	0·001	10·0	8·5	0·372	9·7	9·2	0·030	10·6	9·6	0·488	0·001
Dyslipidaemia (%)	60·3	57·7	0·001	63·5	63·3	0·001	65·2	60·1	0·001	60·9	59·9	0·001	58·2	52·2	0·010	56·2	53·7	0·003	0·001
Diabetes (%)	19·0	11·2	0·001	18·1	11·7	0·004	15·3	10·4	0·036	16·8	9·6	0·001	21·5	12·6	0·021	20·6	11·3	0·014	0·001
Hyperglycaemia (%)	15·5	10·8	0·019	16·7	10·7	0·006	14·7	8·6	0·030	21·7	15·2	0·003	12·2	9·0	0·098	12·7	7·6	0·040	0·001
Smoking (%)	25·2	14·0	0·001	18·8	11·6	0·010	20·6	13·7	0·011	23·2	16·8	0·022	28·4	11·9	0·001	30·5	17·9	0·001	0·001

†Survey regression analysis adjusted for each town unit for average age and gender.

‡Linear and logistic regression models adjusted for age and gender.